SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
acel12211-sup-0001-FigS1.jpgimage/jpg890KFig. S1 Percent of initial body weight.
acel12211-sup-0002-FigS2.jpgimage/jpg851KFig. S2 Kaplan–Meier survival curves for control mice on HF diet (HF, n = 10) and mice treated with schedule R1 (n = 10) and R3 (n = 9).
acel12211-sup-0003-FigS3.jpgimage/jpg622KFig. S3 Commassie Blue-stained membrane of liver blots shown in Figure 4A to confirm equal loading.
acel12211-sup-0004-FigS4.jpgimage/jpg984KFig. S4 Levels of p-S6 and p-AKT in kidneys of surviving mice.
acel12211-sup-0005-FigS5.jpgimage/jpg1058KFig. S5 Levels of fasted and nonfasted glucose and insulin in blood plasma of male mice.
acel12211-sup-0006-FigS6.jpgimage/jpg803KFig. S6 Correlation between metabolic parameters in fasted plasma.
acel12211-sup-0007-FigS7.jpgimage/jpg875KFig. S7 Kaplan–Meier survival curves.
acel12211-sup-0008-TableS1.xlsapplication/msexcel14KTable S1 Survival curve high-fat control (HF) and high fat + rapamycin-treated group 2 (HF+rapamycin (group 2)).
acel12211-sup-0009-TableS2.xlsapplication/msexcel16KTable S2 Survival curve high-fat control (HF) and high fat + rapamycin-treated groups (HF+rapamycin all groups).

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.